Moderna, Inc. (MRNA) vs Tesla, Inc. (TSLA): Which Is the Better Buy in 2026?
As of 2026-08-03, MRNA is fairly valued at $55, with a DCF intrinsic value of $67 and a margin of safety of 18%. TSLA is overvalued at $311, with an intrinsic value of $143 and a margin of safety of -118%. Of the two, MRNA has the wider margin of safety.
Rewards
- ★Altman Z-Score of 19.94 indicates very low bankruptcy risk — the company is firmly in the safe zone.
- ★Net debt/EBITDA of -2.6x means the company holds more cash than debt — a net cash position.
Risks
- ⚠ROIC has declined by 67.4 percentage points over the past 4 years, which may signal competitive erosion.
- ⚠Gross margin of -66.0% is low, suggesting a competitive or commodity-like market with limited pricing power.
- ⚠Moderna, Inc. scores only 17/100 on the Economic Moat Score, suggesting limited durable competitive advantages.
- ⚠ROIC has declined by 21.5 percentage points over the past 4 years, which may signal competitive erosion.
- ⚠Gross margin of 18.9% is low, suggesting a competitive or commodity-like market with limited pricing power.
- ⚠Share count has increased by 19% over the past 4 years, diluting existing shareholders.
Key Valuation Metrics
Learn more →Historical Fundamentals
Learn more →Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.
Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.
Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.
$1 Retained Earnings Test
Learn more →> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
Discounted Cash Flow (DCF) Analysis
Learn more →Reverse DCF — Market-Implied Growth
Learn more →What growth rate is the market pricing in at $55?
Market pricing in significantly higher growth than history — aggressive.
What growth rate is the market pricing in at $311?
The market implies +47.0% Owner Earnings growth, above historical trends.
Standard FCF implies a demanding +43.3%, reflecting heavy growth investment.
Economic Moat Score
Learn more →No durable competitive advantage detected. The business shows limited evidence of pricing power, consistent returns, or capital efficiency.
No durable moat detected, though revenue predictability shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.
Forensic Accounting
Learn more →Insufficient data for Beneish M-Score calculation (requires 2+ years).
M-Score Trend
Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
Ownership Breakdown
Learn more →High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.
Insider Buying Activity
Learn more →Open market purchases · includes direct & indirect ownership · excludes option exercises.
Insider Selling Activity
Learn more →Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.
🎭 Mr. Market's Mood
Learn more →"Market is pessimistic — investigate whether fears are temporary or structural"
"Market is pessimistic — investigate whether fears are temporary or structural"
Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
⚖️ Buffett Signal
Learn more →The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.
The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.
Frequently Asked Questions: MRNA vs TSLA
Is Moderna, Inc. or Tesla, Inc. more undervalued in 2026?▼
Based on our discounted cash flow model, MRNA trades at a 18.2% margin of safety (intrinsic value $67 vs. price $55), compared to TSLA's -117.9% margin of safety (intrinsic $143 vs. $311).
Which stock has a wider economic moat, Moderna, Inc. or Tesla, Inc.?▼
TSLA scores 31/100 (None moat), while MRNA scores 17/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.
Is Moderna, Inc. in financial distress?▼
MRNA's Altman Z-Score of 2.5 places it in the Grey zone, signaling elevated bankruptcy risk. TSLA scores 19.9 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.
Which company has better free cash flow, Moderna, Inc. or Tesla, Inc.?▼
Moderna, Inc. (MRNA) generates a 1.4% free cash flow yield, compared to Tesla, Inc.'s 0.4%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.
Which stock has higher return on invested capital, Moderna, Inc. or Tesla, Inc.?▼
TSLA earns 1.1% ROIC versus MRNA's -122.0%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.